{
  "created_at": "Mon Jul 19 21:24:23 +0000 2021",
  "id_str": "1417118288988020740",
  "full_text": "BioNTech, the company behind one of the Covid-19 vaccines, has agreed to acquire a U.S. manufacturing plant from a unit of Gilead Sciences in a deal aimed at strengthening its core business of developing cutting-edge cancer therapies https://t.co/yi9AHRhUUa",
  "display_text_range": [
    0,
    257
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/yi9AHRhUUa",
        "expanded_url": "https://on.wsj.com/2TjB1xh",
        "display_url": "on.wsj.com/2TjB1xh",
        "indices": [
          234,
          257
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 35,
  "favorite_count": 81,
  "possibly_sensitive": false,
  "original_created_at": "Mon Jul 19 13:45:03 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "Covid-19ワクチンの1つを開発したBioNTech社は、コアビジネスである最先端の癌治療法の開発を強化するために、Gilead Sciences社のユニットから米国の製造工場を買収することに合意しました。https://t.co/yi9AHRhUUa"
    },
    {
      "locale": "zh",
      "full_text": "Covid-19疫苗之一的公司BioNTech已同意从吉利德科学公司的一个部门收购一家美国制造厂，这项交易旨在加强其开发尖端癌症疗法的核心业务https://t.co/yi9AHRhUUa。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "Covid-19疫苗之一的公司BioNTech已同意從吉利德科學公司的一個部門收購一家美國製造廠，這項交易旨在加強其開發尖端癌症療法的核心業務https://t.co/yi9AHRhUUa。"
    }
  ]
}